Identification of Hendra virus G glycoprotein residues that are critical for receptor binding

Kimberly A Bishop1, Tzanko S Stantchev, Andrew C Hickey

  • 1Department of Microbiology and Immunology, Uniformed Services University, Bethesda, MD 20814, USA.

Journal of Virology
|March 23, 2007
PubMed

Insights

Researchers identified key residues in the Hendra virus (HeV) G glycoprotein essential for binding to host cell receptors ephrinB2 and ephrinB3, crucial for viral entry and infection. These findings advance our understanding of paramyxovirus-host interactions.

Area of Science:

  • Virology
  • Molecular Biology
  • Structural Biology

Background:

  • Hendra virus (HeV) is an emerging paramyxovirus infecting mammals, including humans.
  • HeV entry relies on fusion (F) and attachment (G) glycoproteins, with G binding ephrinB2/B3 receptors.

Purpose of the Study:

  • To identify the specific amino acid residues within the HeV G glycoprotein responsible for ephrinB2 and ephrinB3 receptor binding.
  • To elucidate the structural and functional significance of these residues in viral attachment and entry.

Main Methods:

  • Alanine-scanning mutagenesis was employed to generate a panel of HeV G glycoprotein mutants.
  • Coprecipitation assays were used to assess the binding affinity of mutant G glycoproteins to ephrinB2 and ephrinB3.
  • Monoclonal antibody binding and F glycoprotein coprecipitation were evaluated to confirm protein integrity and function.

Main Results:

  • Seven single-amino-acid substitutions (D257A, D260A, G439A, K443A, G449A, K465A, D468A) significantly impaired HeV G binding to ephrinB2/B3.
  • Mutations reduced the ability of G to promote membrane fusion with F.
  • Mutant G glycoproteins remained capable of binding and coprecipitating with F, indicating retained structural integrity.

Conclusions:

  • Specific residues in the HeV G glycoprotein form a discontinuous binding domain for ephrinB2 and ephrinB3.
  • These findings provide critical insights into the molecular mechanisms of HeV attachment and entry.
  • The identified residues are crucial for HeV pathogenesis and potential therapeutic targeting.